Health-related quality of life associated with irritable bowel syndrome: Comparison with other chronic diseases

被引:172
作者
Frank, L
Kleinman, L
Rentz, A
Ciesla, G
Kim, JJ
Zacker, C
机构
[1] MEDTAP Int Inc, Ctr Hlth Outcomes Res, Bethesda, MD 20814 USA
[2] Duke Univ, Duke Clin Res Inst, Durham, NC 27706 USA
[3] Novartis Pharmaceut Corp, E Hanover, NJ USA
关键词
irritable bowel syndrome; quality of life; SF-36; health-related quality of life;
D O I
10.1016/S0149-2918(02)85143-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Despite the rapidly growing body of literature on health-related quality of life (HRQoL), placing the results in a context that is meaningful to clinicians and patients is often overlooked. Objective: This study sought to quantify the impact of irritable bowel syndrome (IBS) on HRQoL by comparing the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) scores of IBS patients with normative US data and with the scores of patients having other chronic gastrointestinal (GI) and non-GI disorders. Methods: Two IBS reference groups were identified from the published literature: a largely untreated community sample of health maintenance organization (HMO) members (N = 92) and a sample of patients with IBS recruited through clinics and in the community (N = 140). SF-36 scores for these groups were compared with published US population norms (N = 2474) and with published scores for 3 other IBS samples (N = 464); a sample with other chronic GI disorders (dyspepsia [N = 126], gastroesophageal reflux disease [GERD] [N = 516]); and samples with other chronic episodic disorders (asthma [N = 375], migraine [N = 303], panic disorder [N = 73], rheumatoid arthritis [N = 693]). Results: The scores of patients in both IBS reference groups were significantly lower on several SF-36 domains than those of the US normative population (P < 0.003). Scores on several SF-36 scales were also significantly lower in the IBS reference groups compared with the GERD, asthma, and migraine samples (P < 0.003). Depending on the IBS sample used, scores did not differ or were higher compared with those in the sample with dyspepsia. Relative to the samples with panic disorder and rheumatoid arthritis, the IBS groups had significantly higher scores on most SF-36 domains (P < 0.003). Scores for the HMO reference group were generally higher than those for the clinic/community reference group. Conclusions: Based on the results of this analysis, IBS is associated with impairment of HRQoL relative to US population norms and to populations with GERD, asthma, or migraine, HRQoL appears to be greater in patients with IBS than in those with panic disorder or rheumatoid arthritis, although the relative symptom severity in these samples was not known.
引用
收藏
页码:675 / 689
页数:15
相关论文
共 23 条
  • [1] Constipation, diarrhea, and irritable bowel syndrome
    Browning, SM
    [J]. PRIMARY CARE, 1999, 26 (01): : 113 - +
  • [2] Quality of life in patients with panic disorder
    Candilis, PJ
    McLean, RYS
    Otto, MW
    Manfro, GG
    Worthington, JJ
    Penava, SJ
    Marzol, PC
    Pollack, MH
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 1999, 187 (07) : 429 - 434
  • [3] UNITED-STATES HOUSEHOLDER SURVEY OF FUNCTIONAL GASTROINTESTINAL DISORDERS - PREVALENCE, SOCIODEMOGRAPHY, AND HEALTH IMPACT
    DROSSMAN, DA
    LI, ZM
    ANDRUZZI, E
    TEMPLE, RD
    TALLEY, NJ
    THOMPSON, WG
    WHITEHEAD, WE
    JANSSENS, J
    FUNCHJENSEN, P
    CORAZZIARI, E
    RICHTER, JE
    KOCH, GG
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (09) : 1569 - 1580
  • [4] Irritable bowel syndrome: A technical review for practice guideline development
    Drossman, DA
    Whitehead, WE
    Camilleri, M
    [J]. GASTROENTEROLOGY, 1997, 112 (06) : 2120 - 2137
  • [5] Drossman DA, 2000, AM J GASTROENTEROL, V95, P999
  • [6] EISEN GM, 2000, 65 ANN SCI M AM COLL
  • [7] The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress
    Francis, CY
    Morris, J
    Whorwell, PJ
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (02) : 395 - 402
  • [8] The impact of irritable bowel syndrome on health-related quality of life
    Gralnek, IM
    Hays, RD
    Kilbourne, A
    Naliboff, B
    Mayer, EA
    [J]. GASTROENTEROLOGY, 2000, 119 (03) : 654 - 660
  • [9] Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome
    Hahn, BA
    Kirchdoerfer, LJ
    Fullerton, S
    Mayer, E
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (03) : 547 - 552
  • [10] Jhingran P, 1996, J FAM PRACTICE, V42, P36